ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Keeffe, S
Right arrow Articles by Finnegan, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Keeffe, S
Right arrow Articles by Finnegan, P
Eur Respir J 1991; 4: 932-936
Copyright © ERS Journals Ltd 1991


Original Articles

Immunoglobulin G subclasses and spirometry in patients with chronic obstructive pulmonary disease

S O'Keeffe, A Gzel, R Drury, M Cullina, J Greally, and P Finnegan

Immunoglobulin G (IgG) subclass levels were measured in 58 patients with chronic obstructive pulmonary disease (COPD) and in 125 healthy controls. Total IgG values were significantly lower in the 27 COPD patients on steroid therapy compared with patients not taking steroids (8.31 (0.14) vs 9.80 (0.14), p less than 0.05), geometric mean (log SD). Total IgG (9.80 (0.14) vs 12.18 (0.16), p less than 0.005), IgG1 (5.87 (0.19) vs 6.68 (0.12), p less than 0.05) and IgG2 levels (2.75 (0.21) vs 3.70 (0.20), p less than 0.005) were significantly reduced in the COPD patients not taking steroids compared with the controls. IgG3 values were significantly elevated in smokers compared with nonsmokers in both the control and COPD groups. Fifteen COPD patients (25.9%) had a low level of one or more subclasses. IgG2 subclass deficiency was the most common, being present in 9 patients. A significant correlation was found between forced expiratory volume in one second (FEV1) and IgG2 subclass levels (r = 0.415; p less than 0.005). IgG subclass deficiencies may contribute to the development and progression of respiratory disease in COPD patients.


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
N. H. Yip, D. J. Lederer, S. M. Kawut, J. S. Wilt, F. D'Ovidio, Y. Wang, E. Dwyer, J. R. Sonett, and S. M. Arcasoy
Immunoglobulin G Levels before and after Lung Transplantation
Am. J. Respir. Crit. Care Med., April 15, 2006; 173(8): 917 - 921.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A J Sandford and E K Silverman
Chronic obstructive pulmonary disease * 1: Susceptibility factors for COPD the genotype-environment interaction
Thorax, August 1, 2002; 57(8): 736 - 741.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
P. J Barnes
Genetics and pulmonary medicine bullet  9: Molecular genetics of chronic obstructive pulmonary disease
Thorax, March 1, 1999; 54(3): 245 - 252.
[Full Text]


Home page
ThoraxHome page
S L Hill, J L Mitchell, D Burnett, and R A Stockley
IgG subclasses in the serum and sputum from patients with bronchiectasis
Thorax, June 1, 1998; 53(6): 463 - 468.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the European Respiratory Society.